Actions

Myeloid lineage-associated markers: Difference between revisions

From haematologyetc.co.uk

No edit summary
No edit summary
Line 7: Line 7:


----
----
These markers can be used to identify myeloid lineage. They allow the diagnosis of AML if there are no lineage-defining markers of B-lineage or T-lineage. Alternatively, if lineage-defining markers of B-lineage or T-lineage are present then consider diagnosis of MPAL.</br>
These markers can be used to identify myeloid lineage. They allow the diagnosis of AML if there are no lineage-defining markers of B-lineage or T-lineage. Alternatively, if lineage-defining markers of B-lineage or T-lineage are present then consider diagnosis of MPAL.</br></br>
<div style="width: 95%">
<div style="width: 95%">
{| class="wikitable" style="border-style: solid; border-width: 5px; color:black"
{| class="wikitable" style="border-style: solid; border-width: 5px; color:black"

Revision as of 19:56, 5 January 2024



These markers can be used to identify myeloid lineage. They allow the diagnosis of AML if there are no lineage-defining markers of B-lineage or T-lineage. Alternatively, if lineage-defining markers of B-lineage or T-lineage are present then consider diagnosis of MPAL.

Assignment of myeloid lineage: Lineage-associated markers
Myeloid lineage assignment using these markers requires that at least two myeloid lineage-associated markers are present
CD117 An early marker of myeloid lineage, seen in up to 80% of AML and vauable in recognising more primitive differentaiion forms (note that aberrant expression is seen in up to 20% of ALL cases)
CD33 A good marker for AML, particularly for those cases with granulocytic maturation, CD33 is often less strongly expressed in AML with monocytic dfferentiation and strongly expressed in APL.
CD13 A good lineage marker for AML that is acquired a little later in differentation than CD117 or CD33; expression of CD13 is often higher than CD33 in AML with monocytic differentiation.